Riskpilot← Back to searchSign inGet full accessModerna Sweden AB
ABActiveOrg 5593272593StockholmManufacture of pharmaceutical preparations · NACE 2120Est. 20212 employees
Revenue 2024
SEK 13,8M
-5% vs 2023
EBITDA margin
2.2%
-52% vs 2023
Equity ratio
43.0%
Financial strength
Net profit 2024
SEK 102K
-73% vs 2023
| Revenue | SEK 13,8M | -5% |
| EBITDA | SEK 302K | -52% |
| Net profit | SEK 102K | -73% |
| Total assets | SEK 13,1M | +10% |
| Equity | SEK 5,6M | +2% |
| Employees | 2 | — |
Legal name
Moderna Sweden AB
Org number
5593272593
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
13 juli 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Utveckling, import, export, marknadsföring och distribution av läkemedel baserade på budbärar-RNA samt därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 14 487 | 13 754 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | — | 0 | 0 | 625 | 302 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | 0 | 0 | 0 | 625 | 302 |
| Net financials | — | 0 | — | 48 | −68 |
| Profit before tax | 0 | 0 | 0 | 673 | 233 |
| Tax | −0 | −0 | — | −289 | −131 |
| Net profit | 0 | 0 | — | 384 | 102 |
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 | 0 | — | 11 825 | 13 062 |
| Equity | 25 | 24 | — | 5 517 | 5 619 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 0 | 0 | — | 6 308 | 7 442 |
| Total debt | — | 0 | — | 6 308 | 7 442 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20212024
Equity ratio
43.0%
This company
38.2%
Market median
+13% vs market
20212024
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
20212024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20212024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20212024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-07-13 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-07-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PR Chief Executive Officer | Chief Executive Officer | 2026 |
EC Chief Auditor | Chief Auditor | 2026 |
| Former (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2021 | |
| Chairman | 2026 | |
| Former (13) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2022 – 2026 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Moderna Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Rickard Öhlén | Chief Executive Officer | 0 companies |
| Eva Carolina Timén | Chief Auditor | 0 companies |
| John Erik Mattias Bankel | Chief Executive Officer | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Emma Maria Birgitta Wik | Deputy Board Member | 0 companies |
| Jed Davidson Larkin | Deputy Board Member | 0 companies |
| Brian Taylor Sandstrom | Chairman | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Chantal Sylvie Friebertshäuser | Deputy Board Member | 0 companies |
| Emelie Sofia Bergh | Deputy Board Member | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Rolf Stefan Janse | Deputy Board Member | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |
| Elin Sofia Gyllenqvist | Deputy Board Member | 0 companies |
| Lisa Anne Kinsella | Chairman | 0 companies |